Expert insights. Personalized for you.
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset MORE
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. MORE
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. MORE
270 
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. I’ve lived long enough to have learned. MORE
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. A study in JAMA published this week analyzed research reports that have measured waste in the U.S. MORE
National health spending in the U.S. is expected to grow by 5.7% MORE
My cousin Arlene got married in Detroit at the classic Book Cadillac Hotel on July 23, 1967, a Sunday afternoon wedding. When Daddy drove us back out to our suburban home about 30 minutes from the fancy hotel, the car radio was tuned to WWJ Newsradio 950, all news all the time. MORE
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health. MORE
Topical Antibiotic Pharmaceuticals Market: Drivers and Restraints. Global topical antibiotic pharmaceuticals is projected to grow rapidly due to increasing prevalence of skin and soft tissue infections as well as increasing availability and affordability of topical antibiotic products. Major drivers for the topical antibiotic pharmaceuticals market are increasing combination of drugs with different chemical moieties for treating various skin infections. MORE
Among all Americans, the most popular approach for improving the health care in the U.S. isn’t repealing or replacing the Affordable Care Act or moving to a Medicare-for-All government-provided plan. MORE
On the demand side of U.S. health care economics, patients are now payors as health consumers with more financial skin in paying medical bills. MORE
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People MORE
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter. MORE
239 
In America, earning lower or middle incomes is a risk factor for having trouble accessing health care and/or paying for it. MORE
Pharmaceutical company executives are testifying in the U.S. Congress this week on the topic of prescription drug costs. One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute. MORE
Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin MORE
The technology has a built-in sensor that can send usage data to a corresponding smartphone app. MORE
212 In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses. MORE
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S. MORE
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. MORE
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs MORE
Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love. MORE
voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Tonight, President Trump will present his fourth annual State of the Union address. MORE
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients MORE
273 
Health care pocketbook issues rank first and second place for Americans in these months leading up to the 2020 Presidential election, according to research from POLITICO and the Harvard Chan School of Public Health published on 19th February 2020. MORE
“Health is now everyone’s business,” Shaheed Peera, Executive Creative Director of Publicis LifeBrands, said this week at the 2019 Cannes Lions awards. MORE
ACA Affordable Care Act Consumer-directed health Financial health Health benefits Health costs Health Economics Health finance Health insurance Health Plans High deductibles Medicines Money and health Personal health finance Pharmaceutical Prescription drugs Workplace benefits MORE
170 
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population. MORE
Today is July 15, and my email in-box is flooded with all flavors of Amazon Prime’d stories in newsletters and product info from ecommerce sites — even those outside of Amazon from beauty retailers, electronics channels, and grocery stores. MORE
Consider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0. MORE
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution. MORE
210 
My take on drug reimportation, which I’ve discussed here on Health Populi, is that if Prime Minister Trudeau can negotiate drug prices with pharmaceutical companies, why shouldn’t President Trump — or previous Presidents of the U.S. MORE
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute. MORE
Gallup notes that Americans are over two times more likely to rank the pharmaceutical industry negatively (58%) as positively (27%). “The pharmaceutical industry’s U.S. from Gallup’s 2019 survey into Americans’ Views of U.S. Business Industry Sectors. MORE
She is concerned about “kicking half of America off of health insurance in 4 years,” pivoting to the “much bigger issue” of pharmaceuticals pricing. MORE
Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019. MORE
ACA Health citizenship Health costs Health Economics Health insurance Health policy Health politics Health reform Health regulation Medicare Money and health Pharmaceutical Pharmacy Prescription drugs TrustHealth care continues to be the top-ranked voting issue in the U.S. MORE
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. People in the U.S. MORE
Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S. MORE
The new year will see a “looming tsunami” of high prices in healthcare, regulation trumping health reform, more business deals reshaping the health/care industry landscape, and patients growing do-it-yourself care muscles, according to Top health industry issues of 2020: Will digital start to show an ROI from the PwC Health Research Institute. I’ve looked forward to reviewing this annual report for the past few years, and always learn something new from PwC’s team of researchers who reach out to experts spanning the industry. In this 14th year of the publication, PwC polled executives from payers, providers, and pharma/life science organizations. Internally, health industry business leaders are prioritizing several workforce strategies in the new year, first and foremost to confront digital transformation. Thi will take the form of digital “upskilling” the existing workforce, as well as complementing the upskilling with deploying technology for tasks previously performed by employees. Beyond current employees, companies in health care are also looking to hire workers with skills to support new capabilities and product offerings. Clearly, digital transformation is top-of-mind for healthcare organizations pondering their workforce strategies for 2020. Externally, health industry leaders realize that the end-users of their products and services are patients assuming the personae of health consumers facing not only clinical decision making, but more challenges in their role in personal financial health care management. The bar chart here gauges strategies providers and payers are undertaking to help make health care more affordable for patients, the new payors. Providers’ tactics that address health care affordability for patients include routing people to lower-cost care options (77%), offering payment plans at 0% interest, developing care delivery programs that focus on high-cost patients, and addressing social determinants of health. For payer organizations, the order of these strategies is a bit different — first is directing patients to lower-cost sites, but offering loans that waive interest for on-time payments and offering health care credit cards rank second, followed by offering payment plans without interest. As patients continue to morph into consumers seeking retail-style service levels, digital channels and platforms will be critical to enable that vision. But on the road to digital transformation, health care organizations will encounter barriers and a bumpy journey. Top of these obstacles to digital Nirvana is ensuring cybersecurity and privacy, the top barrier for each of the three industry segments polled. The second barrier to building out digital strategies is cost, followed by finding and retaining talent, that scarce human capital secret-in-the-digital-sauce. Partnering, too, will be important on the road to digitization in health care across the three industry segments. Health Populi’s Hot Points: In 2020, one certainty in our own forecast is that more patients will take on the role as medical bill payors, as enrollment in high-deductible health plans continues to grow, out-of-pocket costs increase for health care services and goods (esp. specialty medicines), and people expect greater levels of retail-enhanced service from health care providers, plans, and pharma companies. Niall Brennan who leads the Health Care Cost Institute is quoted in the PwC paper, making the case that, “Working Americans will do anything possible to avoid interactions iwth the healthcare system, because it’s a sinkhole of personal time and money.” 2020 also means a Presidential election year, a theme PwC wove into their annual issue roadmap. Their poll of consumers found that 7 in 10 U.S. adults will likely vote on the basis of health care policies or paradigms. Health care access and costs — which tend to be inter-related issues for a patient facing medical issues in the present day — are top-of-mind for Americans these days. They’re a major cause of stress and anxiety, according to the American Psychological Association’s Stress in America study. And, peoples’ financial health is bundled into their overall perceptions of personal health and wellbeing. Niall’s quote on workers avoiding interactions with the health care system due to the “sinkhole” of medical costs threatens industry incumbents in two ways: in the immediate term, a loss of business volume, whether in terms of patients admitted to hospital or clinics, prospective health plan members not signing up for a particular insurance policy, or patients avoiding filling prescriptions due to cost or “financial toxicity.” In the longer run, the legacy health care system is at-risk of becoming less relevant a feature in peoples’ every day lives. PwC mentions Walmart’s most recent retail clinic model in the context of the “tsunami of rising medical prices.” Later in the report, PwC discusses, “A whole new you: deals as makeovers,” examining the question of health care executives’ priorities for making “a deal” in the new year. This last bar chart shows us those priorities: access to new markets top of mind for pharma; ability to remain competitive for both payers and pharma; access to new tech for providers; and, cost-synergies for payors. Making health care more affordable for patients and members ranks fairly low here. So much for patient/consumer centricity. In my book, HealthConsuming: From Health Consumer to Health Citizen , we begin with the premise of the patient-as-payor seeking access to health care, avoiding negative financial side effects and a sense of justice and ownership and control in one’s personal health, health data, and the larger health care system. U.S. voters will vote with both their political ballots and wallets for health care in 2020. The post In 2020, PwC Expects Consumers to Grow DIY Healthcare Muscles As Medical Prices Increase appeared first on HealthPopuli.com. Amazon Connected health Consumer experience Consumer-directed health Data analytics and health Design and health Digital health Employers Financial health Financial toxicity GDPR Health benefits Health care industry Health care information technology Health citizenship Health Consumers Health costs Health ecosystem Health engagement Health marketing Health Plans Health policy Health politics Health privacy Health reform Health regulation Hospitals Internet of things Jobs and health Medical innovation Money and health Patient experience Pharmaceutical Pharmacy Prescription drugs Primary care Retail health Robots Robots and health Self-care Social responsibility User experience UX Value based health Venture capital and health Workplace benefits Workplace wellness MORE
Pharmaceuticals Related Topics 
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
Mobi Health News
MAY 14, 2019
Governments, industry and regulators worldwide are trying to make the pharmaceutical supply chain more bullet-proof and the use of blockchain based track and trace technology has been hailed as a possible solution.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Electronic Health Reporter
AUGUST 28, 2018
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.
Mobi Health News
JULY 15, 2019
The technology has a built-in sensor that can send usage data to a corresponding smartphone app.
Lloyd Price
NOVEMBER 26, 2018
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People
Digital Health
FEBRUARY 3, 2020
Biotech and Genetics Digital Health Entrepreneurship Healthcare Information Technology Innovation Tech Tonics Podcast data science INFORMED initiative iranian immigration Janssen Pharmaceuticals Manatt Health Sean Khozin
.png)
|
Health Populi
OCTOBER 8, 2019
Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. A study in JAMA published this week analyzed research reports that have measured waste in the U.S.
Health Populi
JULY 15, 2019
Today is July 15, and my email in-box is flooded with all flavors of Amazon Prime’d stories in newsletters and product info from ecommerce sites — even those outside of Amazon from beauty retailers, electronics channels, and grocery stores.
Health Populi
JULY 16, 2019
A “one layered delivery network through which patients can move seamlessly as they age and their needs evolve” will be the new health care platform to meet patients’ demands by 2030, according to a forecast from KPMG’s Healthcare and Life Sciences Institute.
Health Populi
APRIL 10, 2019
Pharmaceutical company executives are testifying in the U.S. Congress this week on the topic of prescription drug costs. One of those medicines, insulin, cost a patient $5,705 for a year’s supply in 2016, double what it cost in 2012, according to the Health Care Cost Institute.
Health Populi
APRIL 17, 2019
Consider the voice of a patient before the advent of the Internet in the digital 1.0 world, and then the proliferation of social networks in v 2.0.
|
Health Populi
OCTOBER 15, 2019
Patients’ experiences with the health care industry fall short of their interactions with other industries — namely online retail, online banking and online travel, a new survey from Cedar, a payments company, learned. Survata conducted the study for Cedar among 1,607 online U.S.
Health Populi
FEBRUARY 4, 2020
voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Tonight, President Trump will present his fourth annual State of the Union address.
FierceHealthIT
JUNE 22, 2018
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset
Health Populi
JULY 11, 2019
In May this year, Civica Rx signed an agreement with Xellia Pharmaceuticals to supply essential antibiotics to Civica’s member health systems. The health/care ecosystem continues to morph as the stakeholder groups themselves are blurring across and outside of their core businesses.
Electronic Health Reporter
OCTOBER 25, 2018
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter.
Health Populi
FEBRUARY 20, 2020
Health care pocketbook issues rank first and second place for Americans in these months leading up to the 2020 Presidential election, according to research from POLITICO and the Harvard Chan School of Public Health published on 19th February 2020.
Health Populi
SEPTEMBER 4, 2019
Gallup notes that Americans are over two times more likely to rank the pharmaceutical industry negatively (58%) as positively (27%). “The pharmaceutical industry’s U.S. from Gallup’s 2019 survey into Americans’ Views of U.S. Business Industry Sectors.
Health Populi
JANUARY 30, 2020
ACA Health citizenship Health costs Health Economics Health insurance Health policy Health politics Health reform Health regulation Medicare Money and health Pharmaceutical Pharmacy Prescription drugs TrustHealth care continues to be the top-ranked voting issue in the U.S.
Health Populi
DECEMBER 2, 2019
The idea of health care consumerism isn’t just an American discussion, Deloitte points out in its 2019 global survey of healthcare consumers report, A consumer-centered future of health.
Health Populi
OCTOBER 28, 2019
patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. People in the U.S.
Health Populi
MARCH 29, 2019
Health Consumers Health costs Health Economics Health insurance Health Plans Health policy Health politics Hospitals Pharmaceutical Prescription drugsThere’s little agreement between Democrats and Republicans on a plethora of issues in American public life. But one issue that brings U.S.
Health Populi
FEBRUARY 6, 2020
Among all Americans, the most popular approach for improving the health care in the U.S. isn’t repealing or replacing the Affordable Care Act or moving to a Medicare-for-All government-provided plan.
Health Populi
JANUARY 30, 2020
In America, earning lower or middle incomes is a risk factor for having trouble accessing health care and/or paying for it.
Health Populi
DECEMBER 25, 2018
Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love.
Mobi Health News
JUNE 23, 2019
The pharmaceutical giant will offer Popit’s pill detection device to rheumatoid arthritis patients
Health Populi
JUNE 27, 2019
She is concerned about “kicking half of America off of health insurance in 4 years,” pivoting to the “much bigger issue” of pharmaceuticals pricing.
Health Populi
JULY 1, 2019
And PLM did business deals with large pharmaceutical companies who wanted the data to advance their research and development efforts – that’s how the PLM business was primarily funded. By Susannah Fox, Jane Sarasohn-Kahn and Lisa Suennen. I’ve lived long enough to have learned.
Health Populi
JULY 2, 2019
My take on drug reimportation, which I’ve discussed here on Health Populi, is that if Prime Minister Trudeau can negotiate drug prices with pharmaceutical companies, why shouldn’t President Trump — or previous Presidents of the U.S.
Health Populi
JANUARY 29, 2019
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs
Health Populi
APRIL 24, 2019
Pharmaceuticals garner the lowest score at 57, compared with biotech and life sciences at 64. The 2019 Edelman Trust Barometer measured the biggest gap in trust for the healthcare industry between the U.S. “informed public” and the mass population.
Health Populi
AUGUST 7, 2019
Marc Iskowitz, Executive Editor of MM&M, warmly welcomed me to the Haymarket Media soundproof studio in New York City yesterday. We’d been trying to schedule meeting up to do a live podcast since February, and we finally got our mutual acts together on 6th August 2019.
Health Populi
DECEMBER 11, 2019
The new year will see a “looming tsunami” of high prices in healthcare, regulation trumping health reform, more business deals reshaping the health/care industry landscape, and patients growing do-it-yourself care muscles, according to Top health industry issues of 2020: Will digital start to show an ROI from the PwC Health Research Institute. I’ve looked forward to reviewing this annual report for the past few years, and always learn something new from PwC’s team of researchers who reach out to experts spanning the industry. In this 14th year of the publication, PwC polled executives from payers, providers, and pharma/life science organizations. Internally, health industry business leaders are prioritizing several workforce strategies in the new year, first and foremost to confront digital transformation. Thi will take the form of digital “upskilling” the existing workforce, as well as complementing the upskilling with deploying technology for tasks previously performed by employees. Beyond current employees, companies in health care are also looking to hire workers with skills to support new capabilities and product offerings. Clearly, digital transformation is top-of-mind for healthcare organizations pondering their workforce strategies for 2020. Externally, health industry leaders realize that the end-users of their products and services are patients assuming the personae of health consumers facing not only clinical decision making, but more challenges in their role in personal financial health care management. The bar chart here gauges strategies providers and payers are undertaking to help make health care more affordable for patients, the new payors. Providers’ tactics that address health care affordability for patients include routing people to lower-cost care options (77%), offering payment plans at 0% interest, developing care delivery programs that focus on high-cost patients, and addressing social determinants of health. For payer organizations, the order of these strategies is a bit different — first is directing patients to lower-cost sites, but offering loans that waive interest for on-time payments and offering health care credit cards rank second, followed by offering payment plans without interest. As patients continue to morph into consumers seeking retail-style service levels, digital channels and platforms will be critical to enable that vision. But on the road to digital transformation, health care organizations will encounter barriers and a bumpy journey. Top of these obstacles to digital Nirvana is ensuring cybersecurity and privacy, the top barrier for each of the three industry segments polled. The second barrier to building out digital strategies is cost, followed by finding and retaining talent, that scarce human capital secret-in-the-digital-sauce. Partnering, too, will be important on the road to digitization in health care across the three industry segments. Health Populi’s Hot Points: In 2020, one certainty in our own forecast is that more patients will take on the role as medical bill payors, as enrollment in high-deductible health plans continues to grow, out-of-pocket costs increase for health care services and goods (esp. specialty medicines), and people expect greater levels of retail-enhanced service from health care providers, plans, and pharma companies. Niall Brennan who leads the Health Care Cost Institute is quoted in the PwC paper, making the case that, “Working Americans will do anything possible to avoid interactions iwth the healthcare system, because it’s a sinkhole of personal time and money.” 2020 also means a Presidential election year, a theme PwC wove into their annual issue roadmap. Their poll of consumers found that 7 in 10 U.S. adults will likely vote on the basis of health care policies or paradigms. Health care access and costs — which tend to be inter-related issues for a patient facing medical issues in the present day — are top-of-mind for Americans these days. They’re a major cause of stress and anxiety, according to the American Psychological Association’s Stress in America study. And, peoples’ financial health is bundled into their overall perceptions of personal health and wellbeing. Niall’s quote on workers avoiding interactions with the health care system due to the “sinkhole” of medical costs threatens industry incumbents in two ways: in the immediate term, a loss of business volume, whether in terms of patients admitted to hospital or clinics, prospective health plan members not signing up for a particular insurance policy, or patients avoiding filling prescriptions due to cost or “financial toxicity.” In the longer run, the legacy health care system is at-risk of becoming less relevant a feature in peoples’ every day lives. PwC mentions Walmart’s most recent retail clinic model in the context of the “tsunami of rising medical prices.” Later in the report, PwC discusses, “A whole new you: deals as makeovers,” examining the question of health care executives’ priorities for making “a deal” in the new year. This last bar chart shows us those priorities: access to new markets top of mind for pharma; ability to remain competitive for both payers and pharma; access to new tech for providers; and, cost-synergies for payors. Making health care more affordable for patients and members ranks fairly low here. So much for patient/consumer centricity. In my book, HealthConsuming: From Health Consumer to Health Citizen , we begin with the premise of the patient-as-payor seeking access to health care, avoiding negative financial side effects and a sense of justice and ownership and control in one’s personal health, health data, and the larger health care system. U.S. voters will vote with both their political ballots and wallets for health care in 2020. The post In 2020, PwC Expects Consumers to Grow DIY Healthcare Muscles As Medical Prices Increase appeared first on HealthPopuli.com. Amazon Connected health Consumer experience Consumer-directed health Data analytics and health Design and health Digital health Employers Financial health Financial toxicity GDPR Health benefits Health care industry Health care information technology Health citizenship Health Consumers Health costs Health ecosystem Health engagement Health marketing Health Plans Health policy Health politics Health privacy Health reform Health regulation Hospitals Internet of things Jobs and health Medical innovation Money and health Patient experience Pharmaceutical Pharmacy Prescription drugs Primary care Retail health Robots Robots and health Self-care Social responsibility User experience UX Value based health Venture capital and health Workplace benefits Workplace wellness
Health Populi
FEBRUARY 21, 2019
National health spending in the U.S. is expected to grow by 5.7%
Health Populi
NOVEMBER 19, 2019
My cousin Arlene got married in Detroit at the classic Book Cadillac Hotel on July 23, 1967, a Sunday afternoon wedding. When Daddy drove us back out to our suburban home about 30 minutes from the fancy hotel, the car radio was tuned to WWJ Newsradio 950, all news all the time.
Health Populi
MARCH 6, 2019
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them.
Health Populi
NOVEMBER 5, 2019
On the demand side of U.S. health care economics, patients are now payors as health consumers with more financial skin in paying medical bills.
Health Populi
AUGUST 7, 2018
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.
Health Populi
OCTOBER 22, 2019
ACA Affordable Care Act Consumer-directed health Financial health Health benefits Health costs Health Economics Health finance Health insurance Health Plans High deductibles Medicines Money and health Personal health finance Pharmaceutical Prescription drugs Workplace benefits
Health Populi
JUNE 18, 2019
“Health is now everyone’s business,” Shaheed Peera, Executive Creative Director of Publicis LifeBrands, said this week at the 2019 Cannes Lions awards.
Let's personalize your content